Bioprospect Ltd v Solagran Ltd [2010] FCA 1081

Bioprospect Ltd v Solagran Ltd [2010] FCA 1081

The application for extension of the interlocutory injunction was dismissed because Bioprospect did not establish that damages would not be an adequate remedy or that the balance of convenience favoured maintaining the restraint. While a prima facie case was assumed, no real risk was shown of assets being dissipated, and Solagran’s property rights prevailed given absence of evidence it would sell the shares to defeat relief. The application for amendment of pleadings was allowed on the condition that clearer particulars be provided.

Parties
Applicant: Bioprospect Ltd ACN 008 130 336; First Respondent: Solagran Ltd ACN 002 592 396; Second Respondent: Vagif Soultanovich Soultanov; Third Respondent: Denis Bertram Kilroy; Fourth Respondent: Nova Vita Pty Ltd ACN 109 436 508; Fifth Respondent: Computershare Investor Services Pty Ltd ACN 078 279 277
Jurisdiction
Australia
Judgment Date
01 October 2010
Procedural Posture
Interlocutory Application (injunction/amendment) in Ongoing Commercial Litigation / Post Interim Application, Pre Trial; Ruling on Extension of Interlocutory Injunction and Pleadings Amendment
Outcome
Application for interlocutory injunction dismissed; application to amend pleadings allowed with condition; costs reserved.
Legal Topics
Interlocutory Injunctions, Misleading or Deceptive Conduct, Company Share Capital, Pleading Amendments, Damages
Trade Practices Corporations Law Commercial Law Civil Procedure Interlocutory Injunctions Misleading or Deceptive Conduct Company Share Capital Pleading Amendments +1 more

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 5 Authorities cited 14 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

Bioprospect Ltd ACN 008 130 336

Applicant

Solagran Ltd ACN 002 592 396

First Respondent

Vagif Soultanovich Soultanov

Second Respondent

Denis Bertram Kilroy

Third Respondent

Nova Vita Pty Ltd ACN 109 436 508

Fourth Respondent

Computershare Investor Services Pty Ltd ACN 078 279 277

Fifth Respondent

Procedural Posture

Interlocutory Application (injunction/amendment) in Ongoing Commercial Litigation / Post Interim Application, Pre Trial; Ruling on Extension of Interlocutory Injunction and Pleadings Amendment

Legal Issues

  1. 1 Whether interlocutory injunction should be extended restraining Solagran from dealing with shares pending trial
  2. 2 Whether there is a serious question to be tried regarding misrepresentations
  3. 3 Whether damages would be adequate compensation for loss

Ratio Decidendi

The application for extension of the interlocutory injunction was dismissed because Bioprospect did not establish that damages would not be an adequate remedy or that the balance of convenience favoured maintaining the restraint. While a prima facie case was assumed, no real risk was shown of assets being dissipated, and Solagran’s property rights prevailed given absence of evidence it would sell the shares to defeat relief. The application for amendment of pleadings was allowed on the condition that clearer particulars be provided.

Court Disposition

Application for interlocutory injunction dismissed; application to amend pleadings allowed with condition; costs reserved.

Orders

  • The application for an interlocutory injunction be dismissed.
  • The application to amend the applicant's application be allowed on condition that further particulars are supplied within 7 days.